Atossa Therapeutics, Inc. (ATOS)
2.65
-0.03
(-1.12%)
USD |
NASDAQ |
Aug 26, 16:00
2.67
+0.02
(+0.75%)
After-Hours: 20:00
Atossa Therapeutics Price to Book Value : 0.9857 for Aug. 26, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 26, 2026 | 0.9857 |
| August 25, 2026 | 0.9968 |
| August 24, 2026 | 0.9819 |
| August 21, 2026 | 0.9447 |
| August 20, 2026 | 0.9633 |
| August 19, 2026 | 0.9819 |
| August 18, 2026 | 0.9633 |
| August 17, 2026 | 1.038 |
| August 14, 2026 | 0.9671 |
| August 13, 2026 | 0.9522 |
| August 12, 2026 | 0.8741 |
| August 11, 2026 | 0.8778 |
| August 10, 2026 | 0.8815 |
| August 07, 2026 | 0.8778 |
| August 06, 2026 | 0.9001 |
| August 05, 2026 | 0.8889 |
| August 04, 2026 | 0.8592 |
| August 03, 2026 | 0.8071 |
| July 31, 2026 | 0.7699 |
| July 30, 2026 | 0.8146 |
| July 29, 2026 | 0.8592 |
| July 28, 2026 | 0.8982 |
| July 27, 2026 | 0.8778 |
| July 24, 2026 | 0.8536 |
| July 23, 2026 | 0.8964 |
| Date | Value |
|---|---|
| July 22, 2026 | 0.9038 |
| July 21, 2026 | 0.8927 |
| July 20, 2026 | 0.9261 |
| July 17, 2026 | 0.9261 |
| July 16, 2026 | 0.8889 |
| July 15, 2026 | 0.9075 |
| July 14, 2026 | 0.8406 |
| July 13, 2026 | 0.8927 |
| July 10, 2026 | 0.8815 |
| July 09, 2026 | 0.8778 |
| July 08, 2026 | 0.9113 |
| July 07, 2026 | 0.9261 |
| July 06, 2026 | 0.848 |
| July 02, 2026 | 0.7885 |
| July 01, 2026 | 0.7588 |
| June 30, 2026 | 0.7179 |
| June 29, 2026 | 0.5593 |
| June 26, 2026 | 0.531 |
| June 25, 2026 | 0.50 |
| June 24, 2026 | 0.4943 |
| June 23, 2026 | 0.5367 |
| June 22, 2026 | 0.5169 |
| June 18, 2026 | 0.5678 |
| June 17, 2026 | 0.5607 |
| June 16, 2026 | 0.6271 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Immix Biopharma, Inc. | 4.397 |
| ACADIA Pharmaceuticals, Inc. | 3.897 |
| Alnylam Pharmaceuticals, Inc. | 23.60 |
| Anika Therapeutics, Inc. | 2.114 |
| Savara, Inc. | 8.021 |
Price to Book Value Related Metrics
| PEG Ratio | -0.0045 |
| Price | 2.65 |
| Earnings Yield | -164.0% |
| Market Cap | 26.45M |
| PEGY Ratio | -0.0045 |